nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine—Quinidine barbiturate—GABRA2—conduct disorder	0.175	1	CrCbGaD
Quinidine—ORM1—saliva—conduct disorder	0.0806	0.34	CbGeAlD
Quinidine—KCNK6—brain—conduct disorder	0.033	0.139	CbGeAlD
Quinidine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.0292	0.0496	CbGpPWpGaD
Quinidine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.029	0.0492	CbGpPWpGaD
Quinidine—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.0272	0.0462	CbGpPWpGaD
Quinidine—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.027	0.0459	CbGpPWpGaD
Quinidine—KCNK6—Neuronal System—GABRA2—conduct disorder	0.0221	0.0375	CbGpPWpGaD
Quinidine—KCNK1—Neuronal System—GABRA2—conduct disorder	0.0188	0.0319	CbGpPWpGaD
Quinidine—SLC22A2—Norepinephrine Neurotransmitter Release Cycle—MAOA—conduct disorder	0.0151	0.0257	CbGpPWpGaD
Quinidine—KCNK1—brain—conduct disorder	0.0146	0.0618	CbGeAlD
Quinidine—SLC22A1—Norepinephrine Neurotransmitter Release Cycle—MAOA—conduct disorder	0.0141	0.024	CbGpPWpGaD
Quinidine—SCN1A—brain—conduct disorder	0.0109	0.0459	CbGeAlD
Quinidine—CYP1A2—Methylation—COMT—conduct disorder	0.0106	0.0181	CbGpPWpGaD
Quinidine—KCNK6—Neuronal System—COMT—conduct disorder	0.0106	0.0181	CbGpPWpGaD
Quinidine—KCNK6—Neuronal System—MAOA—conduct disorder	0.0106	0.0179	CbGpPWpGaD
Quinidine—CYP1A1—Estrogen metabolism—COMT—conduct disorder	0.0104	0.0177	CbGpPWpGaD
Quinidine—SCN2A—brain—conduct disorder	0.00997	0.0421	CbGeAlD
Quinidine—CHRM2—Monoamine GPCRs—DRD4—conduct disorder	0.00993	0.0169	CbGpPWpGaD
Quinidine—KCNK1—Neuronal System—COMT—conduct disorder	0.00904	0.0154	CbGpPWpGaD
Quinidine—KCNK1—Neuronal System—MAOA—conduct disorder	0.00897	0.0153	CbGpPWpGaD
Quinidine—SCN3A—brain—conduct disorder	0.00877	0.037	CbGeAlD
Quinidine—SCN5A—brain—conduct disorder	0.00874	0.0369	CbGeAlD
Quinidine—CHRM2—Amine ligand-binding receptors—DRD4—conduct disorder	0.00835	0.0142	CbGpPWpGaD
Quinidine—SLC22A2—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.00768	0.0131	CbGpPWpGaD
Quinidine—SLC22A4—brain—conduct disorder	0.00768	0.0324	CbGeAlD
Quinidine—CHRM2—brain—conduct disorder	0.00744	0.0314	CbGeAlD
Quinidine—SLC22A1—brain—conduct disorder	0.00731	0.0308	CbGeAlD
Quinidine—SLC22A1—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.00716	0.0122	CbGpPWpGaD
Quinidine—CYP1A1—Melatonin metabolism and effects—MAOA—conduct disorder	0.00707	0.012	CbGpPWpGaD
Quinidine—SLCO1A2—brain—conduct disorder	0.00704	0.0297	CbGeAlD
Quinidine—CYP1A1—Oxidative Stress—MAOA—conduct disorder	0.00688	0.0117	CbGpPWpGaD
Quinidine—SLC22A8—brain—conduct disorder	0.00672	0.0284	CbGeAlD
Quinidine—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.00665	0.0113	CbGpPWpGaD
Quinidine—CHRM2—Monoamine GPCRs—HTR2A—conduct disorder	0.00648	0.011	CbGpPWpGaD
Quinidine—SCN5A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00591	0.01	CbGpPWpGaD
Quinidine—KCNH2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00573	0.00974	CbGpPWpGaD
Quinidine—KCNH2—Neuronal System—GABRA2—conduct disorder	0.00566	0.00963	CbGpPWpGaD
Quinidine—CHRM2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00544	0.00926	CbGpPWpGaD
Quinidine—KCNH2—brain—conduct disorder	0.00537	0.0227	CbGeAlD
Quinidine—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.00532	0.00904	CbGpPWpGaD
Quinidine—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.00513	0.00872	CbGpPWpGaD
Quinidine—SLC22A5—brain—conduct disorder	0.00508	0.0214	CbGeAlD
Quinidine—CYP2C8—brain—conduct disorder	0.00492	0.0208	CbGeAlD
Quinidine—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00469	0.00797	CbGpPWpGaD
Quinidine—SLC22A2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00461	0.00784	CbGpPWpGaD
Quinidine—CYP1A1—brain—conduct disorder	0.00454	0.0192	CbGeAlD
Quinidine—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.00451	0.00766	CbGpPWpGaD
Quinidine—SCN5A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00445	0.00756	CbGpPWpGaD
Quinidine—CYP2B6—brain—conduct disorder	0.00441	0.0186	CbGeAlD
Quinidine—CHRM2—GPCRs, Other—DRD4—conduct disorder	0.00441	0.0075	CbGpPWpGaD
Quinidine—ABCC2—NRF2 pathway—SLC6A4—conduct disorder	0.00438	0.00744	CbGpPWpGaD
Quinidine—KCNH2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00431	0.00733	CbGpPWpGaD
Quinidine—SLC22A1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0043	0.00731	CbGpPWpGaD
Quinidine—CHRM2—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.00425	0.00723	CbGpPWpGaD
Quinidine—CYP2E1—brain—conduct disorder	0.00414	0.0175	CbGeAlD
Quinidine—SLC22A4—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00402	0.00683	CbGpPWpGaD
Quinidine—SCN5A—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00362	0.00616	CbGpPWpGaD
Quinidine—SLC22A2—Neuronal System—GABRA2—conduct disorder	0.00353	0.00601	CbGpPWpGaD
Quinidine—KCNH2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00351	0.00597	CbGpPWpGaD
Quinidine—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00347	0.0059	CbGpPWpGaD
Quinidine—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0034	0.00578	CbGpPWpGaD
Quinidine—SLC22A1—Neuronal System—GABRA2—conduct disorder	0.00329	0.0056	CbGpPWpGaD
Quinidine—CYP2D6—brain—conduct disorder	0.00328	0.0138	CbGeAlD
Quinidine—ABCB11—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00326	0.00554	CbGpPWpGaD
Quinidine—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0032	0.00545	CbGpPWpGaD
Quinidine—CHRM2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00305	0.00518	CbGpPWpGaD
Quinidine—SLC22A5—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00302	0.00513	CbGpPWpGaD
Quinidine—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00294	0.00499	CbGpPWpGaD
Quinidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00293	0.00498	CbGpPWpGaD
Quinidine—CHRM2—GPCRs, Other—HTR2A—conduct disorder	0.00288	0.00489	CbGpPWpGaD
Quinidine—SLC22A8—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00273	0.00464	CbGpPWpGaD
Quinidine—KCNH2—Neuronal System—COMT—conduct disorder	0.00273	0.00463	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00272	0.00462	CbGpPWpGaD
Quinidine—KCNH2—Neuronal System—MAOA—conduct disorder	0.00271	0.0046	CbGpPWpGaD
Quinidine—CYP3A7—Biological oxidations—COMT—conduct disorder	0.00251	0.00427	CbGpPWpGaD
Quinidine—CYP3A7—Biological oxidations—MAOA—conduct disorder	0.00249	0.00424	CbGpPWpGaD
Quinidine—CYP3A7—Metapathway biotransformation—COMT—conduct disorder	0.00247	0.00421	CbGpPWpGaD
Quinidine—SLCO1A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00243	0.00412	CbGpPWpGaD
Quinidine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00241	0.0041	CbGpPWpGaD
Quinidine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00239	0.00406	CbGpPWpGaD
Quinidine—ABCB1—brain—conduct disorder	0.00236	0.00995	CbGeAlD
Quinidine—SLCO1B1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00233	0.00395	CbGpPWpGaD
Quinidine—CHRM2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00229	0.0039	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—CGA—conduct disorder	0.00223	0.00379	CbGpPWpGaD
Quinidine—SLC22A2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00222	0.00378	CbGpPWpGaD
Quinidine—ABCC2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00221	0.00375	CbGpPWpGaD
Quinidine—SLC22A2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.0022	0.00375	CbGpPWpGaD
Quinidine—CYP1A1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00211	0.00359	CbGpPWpGaD
Quinidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00211	0.00359	CbGpPWpGaD
Quinidine—SLCO1B1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00207	0.00353	CbGpPWpGaD
Quinidine—SLC22A1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00207	0.00352	CbGpPWpGaD
Quinidine—CHRM2—G alpha (i) signalling events—DRD4—conduct disorder	0.00206	0.00351	CbGpPWpGaD
Quinidine—SLC22A1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00206	0.00349	CbGpPWpGaD
Quinidine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00204	0.00347	CbGpPWpGaD
Quinidine—SCN5A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00192	0.00326	CbGpPWpGaD
Quinidine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00192	0.00326	CbGpPWpGaD
Quinidine—SLC22A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0019	0.00323	CbGpPWpGaD
Quinidine—CHRM2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00187	0.00318	CbGpPWpGaD
Quinidine—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.00187	0.00318	CbGpPWpGaD
Quinidine—KCNH2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00186	0.00316	CbGpPWpGaD
Quinidine—CYP2B6—Biological oxidations—COMT—conduct disorder	0.00186	0.00315	CbGpPWpGaD
Quinidine—CYP2B6—Biological oxidations—MAOA—conduct disorder	0.00184	0.00313	CbGpPWpGaD
Quinidine—CYP2B6—Metapathway biotransformation—COMT—conduct disorder	0.00183	0.00311	CbGpPWpGaD
Quinidine—CYP2E1—Biological oxidations—COMT—conduct disorder	0.00182	0.00309	CbGpPWpGaD
Quinidine—CYP2E1—Biological oxidations—MAOA—conduct disorder	0.0018	0.00307	CbGpPWpGaD
Quinidine—CYP2E1—Metapathway biotransformation—COMT—conduct disorder	0.00179	0.00305	CbGpPWpGaD
Quinidine—SLC22A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00177	0.00301	CbGpPWpGaD
Quinidine—CYP1A1—Biological oxidations—COMT—conduct disorder	0.00171	0.00291	CbGpPWpGaD
Quinidine—CYP1A1—Biological oxidations—MAOA—conduct disorder	0.0017	0.00289	CbGpPWpGaD
Quinidine—SLC22A2—Neuronal System—COMT—conduct disorder	0.0017	0.00289	CbGpPWpGaD
Quinidine—CYP1A1—Metapathway biotransformation—COMT—conduct disorder	0.00169	0.00287	CbGpPWpGaD
Quinidine—SLC22A2—Neuronal System—MAOA—conduct disorder	0.00169	0.00287	CbGpPWpGaD
Quinidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00164	0.00279	CbGpPWpGaD
Quinidine—SLC22A1—Neuronal System—COMT—conduct disorder	0.00159	0.0027	CbGpPWpGaD
Quinidine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00158	0.00268	CbGpPWpGaD
Quinidine—SLC22A1—Neuronal System—MAOA—conduct disorder	0.00157	0.00268	CbGpPWpGaD
Quinidine—CYP2C8—Biological oxidations—COMT—conduct disorder	0.00157	0.00267	CbGpPWpGaD
Quinidine—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.00156	0.00265	CbGpPWpGaD
Quinidine—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.00155	0.00263	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00146	0.00248	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—CGA—conduct disorder	0.00145	0.00247	CbGpPWpGaD
Quinidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00135	0.00229	CbGpPWpGaD
Quinidine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00135	0.00229	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00134	0.00227	CbGpPWpGaD
Quinidine—CYP2D6—Biological oxidations—COMT—conduct disorder	0.00129	0.00219	CbGpPWpGaD
Quinidine—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.00128	0.00218	CbGpPWpGaD
Quinidine—CYP2C9—Biological oxidations—COMT—conduct disorder	0.00128	0.00217	CbGpPWpGaD
Quinidine—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.00127	0.00216	CbGpPWpGaD
Quinidine—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.00127	0.00216	CbGpPWpGaD
Quinidine—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00126	0.00215	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—CGA—conduct disorder	0.00126	0.00214	CbGpPWpGaD
Quinidine—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.00126	0.00214	CbGpPWpGaD
Quinidine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00125	0.00213	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—DRD4—conduct disorder	0.00125	0.00213	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—CGA—conduct disorder	0.00121	0.00206	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—EP300—conduct disorder	0.00117	0.00199	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CGA—conduct disorder	0.00115	0.00195	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—EP300—conduct disorder	0.00113	0.00192	CbGpPWpGaD
Quinidine—CYP1A2—Biological oxidations—COMT—conduct disorder	0.00109	0.00186	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00109	0.00185	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—EP300—conduct disorder	0.00109	0.00185	CbGpPWpGaD
Quinidine—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.00108	0.00184	CbGpPWpGaD
Quinidine—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.00108	0.00183	CbGpPWpGaD
Quinidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00107	0.00182	CbGpPWpGaD
Quinidine—CYP1A1—PPARA activates gene expression—EP300—conduct disorder	0.00105	0.00179	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00104	0.00177	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—CGA—conduct disorder	0.00104	0.00176	CbGpPWpGaD
Quinidine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.00103	0.00175	CbGpPWpGaD
Quinidine—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00099	0.00168	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—CGA—conduct disorder	0.000951	0.00162	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—CGA—conduct disorder	0.000949	0.00161	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000929	0.00158	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—CGA—conduct disorder	0.000885	0.0015	CbGpPWpGaD
Quinidine—CYP3A4—Biological oxidations—COMT—conduct disorder	0.000843	0.00143	CbGpPWpGaD
Quinidine—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.000837	0.00142	CbGpPWpGaD
Quinidine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.000832	0.00141	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	0.000816	0.00139	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—EP300—conduct disorder	0.000764	0.0013	CbGpPWpGaD
Quinidine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.000709	0.0012	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	0.000706	0.0012	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—CGA—conduct disorder	0.000703	0.0012	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—CGA—conduct disorder	0.000689	0.00117	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CGA—conduct disorder	0.000677	0.00115	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—COMT—conduct disorder	0.000655	0.00111	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—MAOA—conduct disorder	0.00065	0.00111	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—CGA—conduct disorder	0.000649	0.0011	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—DRD4—conduct disorder	0.000641	0.00109	CbGpPWpGaD
Quinidine—ABCB11—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000631	0.00107	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—CGA—conduct disorder	0.000595	0.00101	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—COMT—conduct disorder	0.000547	0.00093	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—MAOA—conduct disorder	0.000543	0.000923	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—WASF1—conduct disorder	0.000542	0.000922	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00054	0.000918	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000526	0.000895	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CGA—conduct disorder	0.000519	0.000882	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CGA—conduct disorder	0.000489	0.000831	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CGA—conduct disorder	0.000484	0.000824	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—COMT—conduct disorder	0.000468	0.000795	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—MAOA—conduct disorder	0.000464	0.000789	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	0.000461	0.000784	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00045	0.000765	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—COMT—conduct disorder	0.000429	0.00073	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—COMT—conduct disorder	0.000428	0.000728	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—MAOA—conduct disorder	0.000426	0.000724	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—MAOA—conduct disorder	0.000425	0.000723	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	0.000419	0.000712	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CGA—conduct disorder	0.000414	0.000704	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—COMT—conduct disorder	0.000399	0.000679	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—MAOA—conduct disorder	0.000397	0.000674	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—DRD4—conduct disorder	0.000379	0.000644	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CGA—conduct disorder	0.000319	0.000543	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—COMT—conduct disorder	0.000317	0.00054	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—MAOA—conduct disorder	0.000315	0.000536	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—COMT—conduct disorder	0.000311	0.000528	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—MAOA—conduct disorder	0.000309	0.000525	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—COMT—conduct disorder	0.000293	0.000498	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—MAOA—conduct disorder	0.000291	0.000495	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000282	0.00048	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—EP300—conduct disorder	0.000281	0.000477	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—COMT—conduct disorder	0.000269	0.000457	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—MAOA—conduct disorder	0.000267	0.000454	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000259	0.00044	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—HTR2A—conduct disorder	0.000247	0.00042	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—EP300—conduct disorder	0.000234	0.000399	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—COMT—conduct disorder	0.000234	0.000398	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—MAOA—conduct disorder	0.000232	0.000395	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—COMT—conduct disorder	0.000221	0.000375	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—MAOA—conduct disorder	0.000219	0.000372	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—COMT—conduct disorder	0.000219	0.000372	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—MAOA—conduct disorder	0.000217	0.000369	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000211	0.000358	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—EP300—conduct disorder	0.000201	0.000341	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—COMT—conduct disorder	0.000187	0.000318	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—MAOA—conduct disorder	0.000186	0.000315	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—EP300—conduct disorder	0.000184	0.000313	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—EP300—conduct disorder	0.000184	0.000312	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00018	0.000306	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—EP300—conduct disorder	0.000171	0.000291	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—COMT—conduct disorder	0.000144	0.000245	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—MAOA—conduct disorder	0.000143	0.000243	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—EP300—conduct disorder	0.000136	0.000231	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—EP300—conduct disorder	0.000133	0.000227	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—EP300—conduct disorder	0.000131	0.000223	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—EP300—conduct disorder	0.000126	0.000214	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—EP300—conduct disorder	0.000115	0.000196	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—EP300—conduct disorder	0.0001	0.000171	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—EP300—conduct disorder	9.46e-05	0.000161	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—EP300—conduct disorder	9.38e-05	0.000159	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—EP300—conduct disorder	8.01e-05	0.000136	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—EP300—conduct disorder	6.18e-05	0.000105	CbGpPWpGaD
